SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001628280-24-020849
Filing Date
2024-05-07
Accepted
2024-05-07 07:43:31
Documents
64
Period of Report
2024-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q itci-20240331.htm   iXBRL 10-Q 699574
2 EX-10.1 itci-20240321xex101.htm EX-10.1 45273
3 EX-10.2 itci-20240321xex102.htm EX-10.2 81093
4 EX-31.1 itci-20240331xex311.htm EX-31.1 9617
5 EX-31.2 itci-20240331xex312.htm EX-31.2 9645
6 EX-32 itci-20240331xex32.htm EX-32 5425
  Complete submission text file 0001628280-24-020849.txt   4500875

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT itci-20240331.xsd EX-101.SCH 32968
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT itci-20240331_cal.xml EX-101.CAL 59007
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT itci-20240331_def.xml EX-101.DEF 131829
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT itci-20240331_lab.xml EX-101.LAB 463030
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT itci-20240331_pre.xml EX-101.PRE 306335
68 EXTRACTED XBRL INSTANCE DOCUMENT itci-20240331_htm.xml XML 517584
Mailing Address 430 EAST 29TH STREET NEW YORK NY 10016
Business Address 430 EAST 29TH STREET NEW YORK NY 10016 212-923-3344
Intra-Cellular Therapies, Inc. (Filer) CIK: 0001567514 (see all company filings)

IRS No.: 364742850 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36274 | Film No.: 24919656
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)